Trader consensus implies a 75% probability of the CDC issuing a Level 3 Travel Health Notice—recommending travelers reconsider nonessential trips—by December 31, driven by recent escalations in global outbreaks. In the past month, CDC elevated to Level 2 enhanced precautions for meningococcal disease in the Democratic Republic of the Congo (March 24), yellow fever in Venezuela (March 16), chikungunya in Mayotte (March 10), and global polio affecting dozens of countries (March 9), amid updated Level 1 dengue warnings (April 16). These reflect heightened transmission risks from confirmed case surges, including a U.S. measles outbreak exceeding 1,700 cases by early April. Historical patterns show Level 2 alerts often precede Level 3 during sustained multi-disease threats, though model uncertainties and surveillance updates could shift dynamics; watch weekly CDC reports for escalation signals.
Polymarket verilerine atıfta bulunan deneysel AI tarafından oluşturulmuş özet. Bu bir işlem tavsiyesi değildir ve bu piyasanın nasıl çözümlendiğinde hiçbir rolü yoktur. · GüncellendiCDC 31 Aralık'a kadar Seviye 3 uyarısı veriyor mu?
CDC 31 Aralık'a kadar Seviye 3 uyarısı veriyor mu?
Evet
$112,110 Hac.
$112,110 Hac.
31 Ara 2026
Evet
$112,110 Hac.
$112,110 Hac.
31 Ara 2026
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus implies a 75% probability of the CDC issuing a Level 3 Travel Health Notice—recommending travelers reconsider nonessential trips—by December 31, driven by recent escalations in global outbreaks. In the past month, CDC elevated to Level 2 enhanced precautions for meningococcal disease in the Democratic Republic of the Congo (March 24), yellow fever in Venezuela (March 16), chikungunya in Mayotte (March 10), and global polio affecting dozens of countries (March 9), amid updated Level 1 dengue warnings (April 16). These reflect heightened transmission risks from confirmed case surges, including a U.S. measles outbreak exceeding 1,700 cases by early April. Historical patterns show Level 2 alerts often precede Level 3 during sustained multi-disease threats, though model uncertainties and surveillance updates could shift dynamics; watch weekly CDC reports for escalation signals.
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Piyasa Açıldı: Jan 19, 2026, 3:15 PM ET
Hacim
$112,110Bitiş Tarihi
31 Ara 2026Piyasa Açıldı
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus implies a 75% probability of the CDC issuing a Level 3 Travel Health Notice—recommending travelers reconsider nonessential trips—by December 31, driven by recent escalations in global outbreaks. In the past month, CDC elevated to Level 2 enhanced precautions for meningococcal disease in the Democratic Republic of the Congo (March 24), yellow fever in Venezuela (March 16), chikungunya in Mayotte (March 10), and global polio affecting dozens of countries (March 9), amid updated Level 1 dengue warnings (April 16). These reflect heightened transmission risks from confirmed case surges, including a U.S. measles outbreak exceeding 1,700 cases by early April. Historical patterns show Level 2 alerts often precede Level 3 during sustained multi-disease threats, though model uncertainties and surveillance updates could shift dynamics; watch weekly CDC reports for escalation signals.
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Hacim
$112,110Bitiş Tarihi
31 Ara 2026Piyasa Açıldı
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...Trader consensus implies a 75% probability of the CDC issuing a Level 3 Travel Health Notice—recommending travelers reconsider nonessential trips—by December 31, driven by recent escalations in global outbreaks. In the past month, CDC elevated to Level 2 enhanced precautions for meningococcal disease in the Democratic Republic of the Congo (March 24), yellow fever in Venezuela (March 16), chikungunya in Mayotte (March 10), and global polio affecting dozens of countries (March 9), amid updated Level 1 dengue warnings (April 16). These reflect heightened transmission risks from confirmed case surges, including a U.S. measles outbreak exceeding 1,700 cases by early April. Historical patterns show Level 2 alerts often precede Level 3 during sustained multi-disease threats, though model uncertainties and surveillance updates could shift dynamics; watch weekly CDC reports for escalation signals.
Polymarket verilerine atıfta bulunan deneysel AI tarafından oluşturulmuş özet. Bu bir işlem tavsiyesi değildir ve bu piyasanın nasıl çözümlendiğinde hiçbir rolü yoktur. · Güncellendi
Harici bağlantılara dikkat edin.
Harici bağlantılara dikkat edin.
Sıkça Sorulan Sorular